Distinguished Lecture Series ft. Paula T. Hammond
Tuesday, March 30, 2021 – 12:00 noon CT/1:00 pm ET
Nanolayered Drug Release Systems for Regenerative Medicine and Targeted Nanotherapies. Alternating electrostatic assembly is a tool that makes it possible to create ultrathin film coatings that contain highly controlled quantities of one or more therapeutic molecules within a singular construct. These release systems greatly exceed the usual ranges of traditional degradable polymers, ranging from 10 to as high as 40 wt% drug loading within the film. The nature of the layering process enables the incorporation of different drugs within different regions of the thin film architecture; the result is an ability to uniquely tailor both the independent release profiles of each therapeutic, and the order of release of these molecules to the targeted region of the body. We demonstrate the use of this approach to release or present signaling molecules such as growth factors and siRNA and DNA to regulate genes to facilitate tissue regeneration in-situ, address soft tissue wound healing, deliver vaccines from microneedle surfaces, or administer targeted nanotherapies that are highly synergistic for cancer treatments. New developments in targeted cancer therapies for ovarian, lung and brain cancers will be addressed. Translation of these concepts to nanomaterials design for the penetration of difficult physiological barriers, including cartilage penetration for osteoarthritis, will be described.
Distinguished Lecture Series ft. Mina Bissell, PhD
Tuesday, October 8, 2019 – 11:00am
How does a breast cell learn to become a tissue, and what happens when it forgets?
Dr. Bissell is a Distinguished Senior Scientist at the Lawrence Berkeley National Laboratory (LBNL). She is Faculty of four Graduate Groups in UC Berkeley, and in her career, she has challenged several established paradigms, and pioneered the field of tumor microenvironment.
Distinguished Lecture Series ft. Dr. Jim Wells
Thursday, May 2, 2019 – 11:00am
The next installment of the EBICS Distinguished Lecture Series will be delivered by Dr. Jim Wells at Georgia Tech on May 2nd at 12pm EST. Dr. Wells’ research focuses on the pancreas and gastrointestinal organs and the use of 3-D organoids to create models of diabetes and digestive diseases.
Distinguished Lecture Series ft. Dr. Nigel Goldenfeld
Monday, November 26, 2018 – 4:00pm
Dr. Nigel Goldenfeld
1030 National Center for Supercomputing Applications Building, UIUC. Livecast at MIT and GT
University of Illinois – Urbana Champaign and EBICS is pleased to host Nigel Goldenfeld for the next installment of the EBICS Distinguished Lecturer Series. Dr. Goldenfeld will discuss the collective behavior of complex systems and the new laws of physics which describe these emergent states of matter. He will provide a number of examples from recent research in biology and fluid dynamics.
Nigel Goldenfeld holds a Swanlund Endowed Chair and is a Center for Advanced Study Professor in Physics at the University of Illinois at Urbana-Champaign (UIUC). He is the Director of the NASA Astrobiology Institute for Universal Biology at UIUC, and leads the Biocomplexity Group at the University’s Institute for Genomic Biology.
Distinguished Lecture Series ft. Dr. Michael Elowitz
Wednesday, April 4, 2018 – 4:00pm
The Massachusetts Institute of Technology is proud to host Dr. Michael Elowitz as our Distinguished Lecturer for the spring of 2018.
Circuits of interacting proteins can perform a variety of “computational” functions in living cells. They allow cells to encode and decode signals, and respond to complex stimuli. What kinds of design principles allow natural protein circuits to function effectively? How can we design effective synthetic protein circuits? This talk will explore paradigms of natural and synthetic protein circuit design in mammalian cells.
Distinguished Lecture ft. Celeste Nelson
Friday, December 1, 2017 – 11:00am
“Building Tissue Complexity: Lessons from the Tree of Life” by Dr. Celeste Nelson, Ph.D.
Celeste M. Nelson is a Professor in the Departments of Chemical & Biological Engineering and Molecular Biology at Princeton University. She earned S.B. degrees in Chemical Engineering and Biology at MIT in 1998, a Ph.D. in Biomedical Engineering from the Johns Hopkins University School of Medicine in 2003, followed by postdoctoral training in Life Sciences at Lawrence Berkeley National Laboratory until 2007. Her laboratory specializes in using engineered tissues and computational models to understand how mechanical forces direct developmental patterning events during tissue morphogenesis and during disease progression. She has authored more than 100 peer-reviewed publications. Dr. Nelson’s contributions to the fields of tissue mechanics and morphogenesis have been recognized by a number of awards, including a Burroughs Wellcome Fund Career Award at the Scientific Interface (2007), a Packard Fellowship (2008), a Sloan Fellowship (2010), the MIT TR35 (2010), the Allan P. Colburn Award (2011), a Dreyfus Teacher-Scholar Award (2012), and a Faculty Scholars Award from the Howard Hughes Medical Institute (2016).
Distinguished Lecture Series ft. Dr. Lin Mei (Augusta University)
Friday, March 17, 2017 – 5:00pm to 6:00pm
“Synapses, muscular dystrophy, and brain disorders”
University of Illinois – Urbana Champaign and EBICS is pleased to host Lin Mei for the next installment of the EBICS Distinguished Lecturer Series. Dr. Mei will discuss his lab’s recent studies of neuromuscular junction and the neuregulin/ErbB4 signaling in synaptic plasticity. Research in his lab has focused on mechanisms of synapse formation, neurotransmission, and synaptic plasticity. Their studies contribute to a better understanding of these processes and development of potential therapeutic strategies for psychiatric disorders such as schizophrenia, autism, and depression and neurological disorders such as muscular dystrophy, spinal cord injury, and epilepsy.
Dr. Lin Mei is Professor and Chair (Inaugural) of the Department of Neuroscience and Regenerative Medicine, Medical College of Georgia, Augusta University. Dr. Mei served as Director, Institute of Molecular Medicine and Genetics from 2009 to 2014 and has been the Chair of Department of Neuroscience and Regenerative Medicine since 2014. Dr. Mei have received numerous awards Distinguishes Investigator from National Alliance for Research on Schizophrenia and Depression (2008) and Mathilde Solowey Away from Foundation for Advanced Education in Sciences (2008). Dr. Mei is a Fellow of American Association for the Advancement of Science.
Distinguished Lecture Series ft. Dr. George Daley
Tuesday, April 12, 2016 – 11:00am to 12:00pm
Dr. George Daley
“Engineering Cell Fates in Vitro”
Koch Institute at MIT Room 76-156, live broadcast to GT and UIUC
For the most recent installment of the EBICS Distinguished Lecturer Series, EBICS was pleased to host George Daley. Dr. Daley discussed current efforts to differentiate pluripotent stem cells to specific lineages by mimicking embryonic programs, and modes of assessing the fidelity of these cells relative to efforts to directly engineer cells via synthetic biology.
Dr. Daley is currently the Samuel E. Lux IV Professor of Hematology/Oncology and the Director of the Stem Cell Transplantation Program at Boston Children’s Hospital; Professor of Biological Chemistry and Molecular Pharmacology, Medicine, and Pediatrics at Harvard Medical School; an investigator of the Howard Hughes Medical Institute; Associate Director of Children’s Stem Cell Program; and a founding member of the Executive Committee of the Harvard Stem Cell Institute.
Distinguished Lecture Series ft. Dr. Farren Isaacs
Friday, March 4, 2016 – 11:00am to 12:00pm
“Programming Genomes to Expand Life’s Functional Repertoire”
Farren Isaacs is Assistant Professor of Molecular, Cellular and Developmental Biology and Systems Biology at Yale University. He received a B.S.E in Bioengineering from the University of Pennsylvania and Ph.D. in Biomedical Engineering-Bioinformatics at Boston University, where he pioneered the development of synthetic RNA molecules capable of probing and programming cellular function. As a research fellow in genetics at Harvard, he invented enabling technologies for genome engineering. His research is focused on finding ways to construct new genetic codes and reprogrammable cells that serve as factories for chemical, drug and biofuel production. He has been named a “rising young star of science” by Genome Technology Magazine, a Beckman Young Investigator by the Arnold and Mabel Beckman Foundation and recipient of a Young Professor award from DuPont.
Distinguished Lecture Series ft. Dr. Clare Waterman
Tuesday, February 17, 2015 – 4:00pm
Dr. Clare M. Waterman, Ph.D.
NIH Distinguished Investigator Laboratory of Cell and Tissue Morphodynamic
“Integration of Actin Dynamics and Cell Adhesion by a Three-dimensional, Mechanosensative Molecular Clutch”
Forces generated in the actin cytoskeleton are transmitted across transmembrane receptors to the extracellular matrix (ECM) or other cells during directed migration. Force transmission from the cytoskeleton to the receptors is mediated by a series of mechanosensitive regulatable, indirect protein-protein interactions termed the “molecular clutch.” In integrin-based focal adhesions, the proteins making up this linkage are organized into a conserved threedimensional nano-architecture. Molecular clutches of similar architecture likely mediate cell adhesive interactions during tissue morphogenesis, the immune response, and vascular function.
Distinguished Lecture Series ft. Dr. Rudolf Jaenisch
Thursday, September 18, 2014 – 4:00pm
Rudolf Jaenisch, M.D.
Professor of Biology, MIT and White Head Institute – Founding Member
“iPS Cell Technology, Gene Editing and Disease Reseach”
The recent demonstration of in vitro reprogramming using transduction of four transcription factors by Yamanaka and colleagues represents a major advance in the field. However, major questions regarding the mechanism of in vitro reprogramming need to be understood and will be one focus of the talk. A major impediment in realizing the potential of ES and iPS cells to study human diseases is the inefficiency of gene targeting. Methods based on Zn finger or TALEN mediated genome editing have allowed us to overcome the inefficiency of homologous recombination in human pluripotent cells. Using these genome editing approaches we have established efficient protocols to target expressed and silent genes in human ES and iPS cells. The most recent advance comes from the use of the CRISPR/ Cas9 system to engineer ES cells and mice. This technology allows the simultaneous editing of multiple genes and will facilitate establishing relevant models to study human disease. We have used this technology to generate isogenic pairs of cells that differ exclusively at a disease causing mutation. The talk will describe the use of isogenic pairs of mutant and control iPS cells to establish in vitro systems for the study of diseases such as Parkinson’s and Rett syndrome.
Distinguished Lecture Series ft. Dr. Arthur Lander
Tuesday, March 11, 2014 – 4:00pm to 5:00pm
Arthur D. Lander, M.D., Ph.D.
Center for Complex Biological Systems, and Departments of Developmental & Cell Biology and Biomedical Engineering, University of California, Irvine, CA
“The Costs and Consequences of Biological Control”
After a century of great strides in identifying the components and mechanisms out of which living things are constructed, biologists are increasingly turning (or returning) to questions of biological organization: Why are biological systems built the way they are? What explains the presence of the detailed mechanisms and patterns we observe? How much is chance, and how much is necessity? A defining feature of the recent Systems Biology movement is the tendency to explain biological organization in terms of design principles, i.e. strategies for achieving ends dictated by natural selection. Following this approach I will discuss two examples of how selection for the ability to perform diverse tasks imposes constraints on biology, constraints that justify the need for complex patterns of organization that might otherwise seem arbitrary. In one case I will talk about systems that implement robust pattern formation during animal development. In the other I will talk about stem cell systems, which underlie the development and/or maintenance of most tissues and organs, and which provide the context within which cancers arise. In both cases, I will argue that approaching biology as a set of solutions to control problems provides more satisfying answers than are obtained by treating it as merely a complicated example of physics.
Distinguished Lecture Series ft. Dr. Viola Vogel
Thursday, April 4, 2013 – 4:00pm
Professor Viola Vogel
Laboratory of Applied Mechanobiology, Department of Health Sciences and Technology, ETH Zürich, Switzerland
“How Cells and Bacteria Exploit Proteins as Mechano-Chemical Signaling Switches”
The physical and biochemical properties of extracellular matrix and of synthetic materials provide critical cues to cells, from mechano-regulated bacterial adhesion to angiogenesis, and finally to the differentiation of stem cells. It is thus of major importance to gain mechanistic insights into how mechanical stretching of extracellular matrix molecules can alter various cell functions. While investigating these three distinct physiological processes, common motifs are emerging how bacteria and cells take advantage of mechanical forces to regulate the function of proteins by stretching them out of their equilibrium structures. In this context, new assays and techniques were developed that allow probing how the stretching of proteins alters their structure-function relationships. Taken together, new insights into various underpinning mechanotransduction events are emerging how mechanical cues are translated into biochemical signals that ultimately regulate bacterial adhesion and various cellular processes.
Distinguished Lecture Series ft. Dr. Eric Davidson
Friday, November 16, 2012 – 4:00pm
Norman Chandler Professor of Cell Biology, California Institute of Technology
“Gene Network Models and Logic Processing in Development”
Gene regulatory networks (GRNs) control the dynamic spatial patterns of regulatory gene expression in development. Thus, in principle, GRN models may provide system-level, causal explanations of developmental process. To test this assertion, we have transformed a relatively well-established GRN model into a predictive, dynamic Boolean computational model. This Boolean model computes spatial and temporal gene expression according to the regulatory logic and gene interactions specified in a GRN model for embryonic development in the sea urchin. Additional information input into the model included the progressive embryonic geometry and gene expression kinetics. The resulting model predicted gene expression patterns for a large number of individual regulatory genes each hour up to gastrulation (30 h) in four different spatial domains of the embryo. Direct comparison with experimental observations showed that the model predictively computed these patterns with remarkable spatial and temporal accuracy. In addition, we used this model to carry out in silico perturbations of regulatory functions and of embryonic spatial organization. The model computationally reproduced the altered developmental functions observed experimentally. Two major conclusions are that the starting GRN model contains sufficiently complete regulatory information to permit explanation of a complex developmental process of gene expression solely in terms of genomic regulatory code, and that the Boolean model provides a tool with which to test in silico regulatory circuitry and developmental perturbations.
Distinguished Lecture Series ft. Dr. Mark A. Bedau
Wednesday, June 27, 2012 – 1:00pm
Dr. Mark A. Bedau
“How Emergence Drives the (Science and) Ethics of Synthetic Biology”
Distinguished Lecture Series ft. Dr. Stephen Quake
Friday, April 13, 2012 – 4:00pm
Professor of Bioengineering Co-Chair, Department of Bioengineering Investigator, Howard Hughes Medical Institute Stanford University
“Precision Measurement in Biology”
Is biology a quantitative science like physics? I will discuss the role of precision measurement in both physics and biology, and argue that in fact both fields can be tied together by the use and consequences of precision measurement.
The elementary quanta of biology are twofold: the macromolecule and the cell. Cells are the fundamental unit of life, and macromolecules are the fundamental elements of the cell. I will describe how precision measurements have been used to explore the basic properties of these quanta, and more generally how the quest for higher precision almost inevitably leads to the development of new technologies, which in turn catalyze further scientific discovery. In the 21st century, there are no remaining experimental barriers to biology becoming a truly quantitative and mathematical science.
Distinguished Lecture Series ft. Dr. L. Ben Freund
Friday, September 16, 2011 – 4:00pm
Dr. L. Benjamin Freund
Adjunct Professor of Materials Science and Engineering, University of Illinois at Urbana-Champaign; H. L. Goddard University Professor Emeritus, Brown University
“Analysis of Cell Adhesion Phenomena as Observed at Different Size Scales“
Abstract: We discuss several phenomena, each concerned with an aspect of adhesion of a cell to its surroundings or to another cell, but which are observed at different size scales. In each case, recently reported laboratory observations provide a framework for quantitative modeling of the underlying phenomenon. At the smallest scale, we consider the separation of specific molecular bonds under the action of externally applied forces (as observed by Evans and co-workers with the bio-membrane force probe, for example) with a view toward characterization of the bond structure and rate sensitivity from separation data. At an intermediate size scale, we consider a physical basis for the maximum spacing between cell/substrate bonding sites common among several cell types (observed by Spatz and co-workers, for example). It is demonstrated that thermal fluctuations alone imply that membrane bonding cannot occur if bond site spacing is beyond some system specific threshold level. Lastly, at the scale of cell interactions within compact clusters of thousands of cells, we consider the forces that come into play as the shape of such a cluster changes spontaneously (as observed by Morgan and co-workers, for example). Recent progress toward development of mathematical models for each of these phenomena is summarized.
Distinguished Lecture Series ft. Paul Wolpe
Monday, June 27, 2011 – 4:00pm
Paul Root Wolpe
Director of the Emory Center of Ethics
“Ethical Challenges of Stem Cell Research, Synthetic Biology, and Regenerative Medicine”
Distinguished Lecturer Series ft. Dr. Robert Langer
Friday, February 4, 2011 – 4:00pm to 5:00pm
Dr. Robert Langer
MIT Department of Chemical Engineering
“Engineering of Integrated Materials and Cell Based Systems”
I will start by discussing how I – as a chemical engineer – initially got involved in the interface between biology and engineering, which would lead to the isolation of the first angiogenesis inhibitors and the development of controlled release systems for macromolecules. I will then cover the engineering of novel microelectronic systems. Such systems have the ability to sense levels of drugs or other substances in blood. They can also secrete drugs into the bloodstream. Next, the possibility of creating cell based tissues and organs – and the challenges associated with that – will be discussed. Finally, the development of new high-throughput, polymer-based tools that can control the differentiation and growth of stem cells and other cells will be examined.